Trends on Autism Disorder Treatment Market Outlook 2020 – Industry Analysis by Size, Share, Growth Factors, R&D Companies and Foresight to 2026

SEATTLE, March 29, 2021, (PHARMIWEB) — Autism, also known as autism spectrum disorder (ASD), is a set of complex neurological disorders. Major symptoms of ASD include, lack of social skills and speech and non-verbal communication along with repetitive behaviors. The severity of the disease and related symptoms can differ from patient to patient. Early and evident symptoms of ASD can be recorded in individuals between 2-3 years of age. Moreover, the disorder can also be diagnosed in infants that are 18 months old. Although the specific mechanism or cause of the disease is not yet clear, several studies have revealed environmental factors and genetic changes that lead to ASD. According to the U.S. National Library of Medicine, there is no standard treatment currently available for the treatment of ASD, however, various therapies are available that aid in enhancing the ability of infants to grow and learn new skills such as communication therapies, skill training, and therapeutic medicines to control the symptoms of the disorder. A multi-disciplinary diagnostic team of a speech and language therapist, a psychiatrist or psychologist, and a pediatrician aids in diagnosis of ASD.

To learn more about this report, request a sample copy*
* The sample copy includes: Report Summary, Table of Contents, Segmentation, Competitive Landscape, Report Structure, Methodology.

Request a sample copy of this report@ https://www.coherentmarketinsights.com/insight/request-sample/1607

Market Dynamics

Increasing prevalence of mental and neurological disorders is expected to boost growth of the autism disorder treatment market. For instance, according to the National Autistic Society 2016, around 700,000 people suffered from ASD in the U.K., which accounts for 1 in every 100 people suffering from the mental condition. According to the epidemiological data stated by the World Health Organization (WHO), in April 2017, ASD affects 1 per 160 children worldwide. The WHO also suggests that based on the epidemiological studies conducted over past 50 years, the rate of incidence of autism has witnessed an increase, globally.

Moreover, increasing support from governments and non-governmental organizations in the management and treatment of ASD is also expected to boost growth of the autism disorder treatment market. For instance, in May 2014, a resolution was adopted at the 67^th World Health Assembly entitled “Comprehensive and Coordinated Efforts for the Management of Autism Spectrum Disorders (ASD)” that was supported by over 60 countries across the globe, to strengthen their national capacities to address ASD. Increasing R&D for new medicines and growing awareness regarding early diagnosis of ASD is also contributing to growth of the market.

However, several regulatory bodies have imposed stringent regulations for approval and marketing of therapies, which is expected to restrain growth of the autism disorder treatment market. For instance, in May 2017, the U.S. Food and Drug Administration (FDA) shut down operations of Louisiana-based Pick and Pay Inc. /Cili Minerals, a manufacturer of drug and dietary supplements, after finding that the company was falsely marketing products to being able to treat autism.

Tailored Information as per niche requirement:
LIMITED TIME OFFER – Hurry Up!

Get Discount For Buyers UPTO 30% OFF On Any Research Report
Apply Promo Code “CMIFIRST1000” And Get an Instant Discount Of USD 1000

Buy Now This Premium Report to Grow your Business @ https://bit.ly/3u28mcP

Regional Analysis

The market in North America accounts for the largest market share in the global autism disorder treatment market. The market growth is majorly driven by factors such as increasing focus of major players in R&D of new therapies, high prevalence of ASD, and increasing government support for the treatment of the disease. For instance, according to the Centers of Disease Control and Prevention’s (CDC’s) Autism and Developmental Disabilities Monitoring (ADDM) Network 2014 report, around 1 in 59 children were identified with ASD. Moreover, the disease was reported to be four times more common among boys than girls. In 2016, Talk About Curing Autism (TACA), a U.S.-based non-profit organization dedicated to supporting patients with autism, stated that the disease is the fastest growing developmental disability in the U.S. that cost over US$ 238 billion annually, to the country.

The market in Asia Pacific is expected to witness significant growth in the global autism disorder treatment market. The market growth is driven by increasing support of governmental and non-profit organizations for the treatment of ASD. For instance, Action for Autism by the National Center for Autism India pioneered autism movement in India and South-Asia for empowering lives of patients suffering with autism by conducting “Global Giving Program” named Ananda and various other initiatives. This non-profit organization is supported by Department of Social Welfare, Government of India, and it is expected to provide medical and economic support to over 3,000 families in India in 2017.

To get detailed table of content (ToC), please click – https://www.coherentmarketinsights.com/ongoing-insight/toc/1607

Competitive Analysis

Key players operating in the market are focused on approval and launch of new products to expand their product portfolio. For instance, in January 2018, Switzerland-based drug maker, Roche, received the U.S. FDA grant for its breakthrough therapy, Balovaptan, for the treatment of ASD.

Key players operating in the global autism disorder treatment market include, Teva Pharmaceuticals Industries Ltd., Janssen Pharmaceuticals, Inc., Bristol Myers Squibb, Par Sterile Products LLC, F. Hoffman La Roche, Actavis, Inc., Curemark LLC, Pediatric Bioscience, Inc., Novartis AG, Mylan NV, and Pfizer, Inc.

To understand Research Methodology, please click https://www.coherentmarketinsights.com/ongoing-insight/autism-disorder-treatment-market-1607

Market Taxonomy:

On the basis of drug class, the global autism disorder treatment market is segmented into:

• Anticonvolusants
• Antipsychotics
• Insomnia Drugs
• Selective Serotonin Reuptake Inhibitors (SSRIs)
• Others

On the basis of distribution channel, the global autism disorder treatment market is segmented into:

• Hospital Pharmacies
• Retail Pharmacies
• e-Commerce

On the basis of geography, the global autism disorder treatment market is segmented into:

• North America
• Latin America
• Europe
• Asia Pacific
• Middle East
• Africa

Table of Content

Global Autism Disorder Treatment Market Research Report
Section 1: Global Autism Disorder Treatment Industry Overview
Section 2: Global Economic Impact on Autism Disorder Treatment Industry
Section 3: Global Market Competition by Industry Producers
Section 4: Global Productions, Revenue (Value), according to Regions
Section 5: Global Supplies (Production), Consumption, Export, Import, geographically
Section 6: Global Productions, Revenue (Value), Price Trend, Product Type
Section 7: Global Market Analysis, on the basis of Application
Section 8: Autism Disorder Treatment Market Pricing Analysis
Section 9: Market Chain, Sourcing Strategy and Downstream Buyers
Section 10: Strategies and key policies by Distributors/Suppliers/Traders
Section 11: Key Marketing Strategy Analysis, by Market Vendors
Section 12: Market Effect Factors Analysis
Section 13: Global Autism Disorder Treatment Market Forecast

Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having office at global financial capital in the U.S. and sales consultants in United Kingdom and Japan. Our client base includes players from across various business verticals in over 150 countries worldwide. We pride ourselves in catering to clients across the length and width of the horizon, from Fortune 500 enlisted companies, to not-for-profit organization, and startups looking to establish a foothold in the market. We excel in offering unmatched actionable market intelligence across various industry verticals, including chemicals and materials, healthcare, and food & beverages, consumer goods, packaging, semiconductors, software and services, Telecom, and Automotive. We offer syndicated market intelligence reports, customized research solutions, and consulting services.

To know more about us, please visit our website – www.coherentmarketinsights.com

Contact:

Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
Email: sales@coherentmarketinsights.com
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837